Use of IV immunoglobulin was associated with a significantly reduced ICU length of stay in immunocompromised patients with respiratory viral infections.

Intravenous immunoglobulin (IVIG) is a type of medication used to treat people with immunodeficiencies, when the immune ...

The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved ...

With many patients, a critical element of treatment is infusion of intravenous immune globulin (IVIG). Congress should ensure that comparative effectiveness research does not allow for cost ...

With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...

ADMA Biologics reported $107.2M in Q2 2024 revenue, a 78% YoY increase, with ASCENIV being the primary growth driver. See why ...

Study results published in Pediatric Rheumatology suggest that maintaining sufficient serum 25 (OH)-vitamin D levels could positively influence Kawasaki disease outcomes.

ADMA Biologics, Inc.’s ADMA shares skyrocketed 76.2% in the past three months compared with the industry’s growth of 9.6%. The stock also hit a new 52-week high of $19.34 on Sept. 9. The stupendous ...

Analysts have recently evaluated ADMA Biologics and provided 12-month price targets. The average target is $18.25, accompanied by a high estimate of $20.00 and a low estimate of $15.00. Marking an ...

Amgen reports mixed results from Phase 3 trials, with rocatinlimab showing moderate success in atopic dermatitis and Uplizna ...

FcRn market with Vyvgart, poised for growth in autoimmune diseases and supports a bullish outlook. Read more on ARGX here.

Inc. (Nasdaq: TSVT) today announced that the Company, in partnership with study sponsor Bristol Myers Squibb (BMS), will ...